Congress Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-89,557
| Closed | -$305K | – | 392 |
|
|
2024
Q3 | $305K | Sell |
89,557
-939
| -1% | -$3.2K | ﹤0.01% | 345 |
|
|
2024
Q2 | $423K | Sell |
90,496
-1,135
| -1% | -$5.3K | ﹤0.01% | 340 |
|
|
2024
Q1 | $680K | Buy |
91,631
+1,192
| +1% | +$8.85K | ﹤0.01% | 312 |
|
|
2023
Q4 | $916K | Buy |
90,439
+205
| +0.2% | +$2.08K | 0.01% | 320 |
|
|
2023
Q3 | $704K | Buy |
90,234
+120
| +0.1% | +$936 | 0.01% | 325 |
|
|
2023
Q2 | $742K | Buy |
90,114
+565
| +0.6% | +$4.65K | 0.01% | 319 |
|
|
2023
Q1 | $649K | Buy |
89,549
+8,842
| +11% | +$64.1K | 0.01% | 318 |
|
|
2022
Q4 | $716K | Buy |
80,707
+638
| +0.8% | +$5.66K | 0.01% | 321 |
|
|
2022
Q3 | $980K | Buy |
80,069
+1,004
| +1% | +$12.3K | 0.01% | 306 |
|
|
2022
Q2 | $935K | Buy |
79,065
+622
| +0.8% | +$7.36K | 0.01% | 317 |
|
|
2022
Q1 | $1.49M | Buy |
78,443
+7,667
| +11% | +$146K | 0.01% | 302 |
|
|
2021
Q4 | $1.88M | Buy |
70,776
+21
| +0% | +$558 | 0.01% | 287 |
|
|
2021
Q3 | $2.91M | Buy |
70,755
+2,675
| +4% | +$110K | 0.02% | 249 |
|
|
2021
Q2 | $3.86M | Buy |
68,080
+10,440
| +18% | +$591K | 0.03% | 234 |
|
|
2021
Q1 | $2.42M | Buy |
+57,640
| New | +$2.42M | 0.02% | 250 |
|